COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 464: Articles 4631-4640  | Next

Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide analysis of programme data and health system vulnerabilities
Surendra, H., Elyazar, I., Puspaningrum, E., Darmawan, D., Pakasi, T., Lukitosari, E., Sulistyo, S., Deviernur, S., Fuady, A., Thwaites, G., van Crevel, R., Shankar, A., Baird, J. K., Hamers, R.
10.1101/2023.02.09.23285740 — Posted: 2023-02-14
Quantifying the rate and magnitude of the Omicron outbreak in China after sudden exit from 'zero-COVID' restrictions
Goldberg, E. E., Lin, Q., Romero-Severson, E. O., Ke, R.
10.1101/2023.02.10.23285776 — Posted: 2023-02-14
The long COVID evidence gap: comparing self-reporting and clinical coding of long COVID using longitudinal study data linked to healthcare records.
Knuppel, A., Boyd, A., Macleod, J., Chaturvedi, N., Williams, D. M.
10.1101/2023.02.10.23285717 — Posted: 2023-02-14
Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling study
Ghani, A. C.
10.1101/2023.02.09.23285743 — Posted: 2023-02-14
Sarbecoviruses of British Horseshoe Bats; Sequence Variation and Epidemiology
Apaa, T., Withers, A. J., Staley, C. E., Blanchard, A. M., Bennett, M., Bremner-Harrison, S., Chadwick, E. A., Hailer, F., Harrison, S. W. R., Loose, M., Mathews, F., Tarlinton, R. E.
10.1101/2023.02.14.528476 — Posted: 2023-02-14
Transcription regulation of SARS-CoV-2 receptor ACE2 by Sp1: a potential therapeutic target
Han, H., Luo, R.-H., Long, X.-Y., Wang, L.-Q., Zhu, Q., Tang, X.-Y., Zhu, R., Ma, Y.-C., Zheng, Y.-T., Zou, C.-g.
10.1101/2023.02.14.528496 — Posted: 2023-02-14
P-Selectin promotes SARS-CoV-2 interactions with platelets and the endothelium
Moreno, C. L., Castanheira, F. V. S., Stella, A. O., Chung, F., Aggarwal, A., Cole, A. J., Loo, L., Dupuy, A., Kong, Y., Hagimola, L., Fenwick, J., Coleman, P., Wilson, M., Bui-Marinos, M., Hesselson, D., Gamble, J., Passam, F., Turville, S., Kubes, P., Neely, G. G.
10.1101/2023.02.13.528235 — Posted: 2023-02-14
Propylene glycol inactivates respiratory viruses and prevents airborne transmission
Styles, C. T., Zhou, J., Flight, K. E., Brown, J. C., Vanden Oever, M., Peacock, T. P., Wang, Z., Millns, R., O'Neill, J. S., Barclay, W. S., Tregoning, J. S., Edgar, R. S.
10.1101/2023.02.13.528349 — Posted: 2023-02-14
SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster
Wang, Q., Bowen, A. D., Tam, A. R., Valdez, R., Stoneman, E., Mellis, I. A., Gordon, A., Liu, L., Ho, D. D.
10.1101/2023.02.13.528341 — Posted: 2023-02-14
Two dimensions of chemical variation of the human microbiome across body sites and in COVID-19 patients
Dick, J. M.
10.1101/2023.02.12.528246 — Posted: 2023-02-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).